MedTrace Logo

Radicle GI Health RDH™: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal (GI) Health and Related Health Outcomes

NCT07230821 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 550

Last updated 2026-04-21

No results posted yet for this study

Summary

A Randomized, Double-Blind, Placebo-Controlled Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on Gastrointestinal (GI) Health and Related Health Outcomes

Conditions

Interventions

DIETARY_SUPPLEMENT

GI Health Active Product 1

Participants will use their GI Health Active Product 1 as directed for a period of 6 weeks.

DIETARY_SUPPLEMENT

GI Health Product Placebo Control

Participants will use their \[Product Name\] Control as directed for a period of 6 weeks

Sponsors & Collaborators

  • Radicle Science

    lead INDUSTRY

Principal Investigators

  • Susan Hewlings · Radicle Science

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
105 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-16
Primary Completion
2026-12-11
Completion
2026-12-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07230821 on ClinicalTrials.gov